-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, QWcWNdOteOGuOwB1h6qLmdlTFas0rknWCYZ8taBecuvrX6xIk3CZPNOSjjeGjV4k EWU3dTWZ5ut6B0qomM4YOA== 0000950117-02-001834.txt : 20020813 0000950117-02-001834.hdr.sgml : 20020813 20020812183108 ACCESSION NUMBER: 0000950117-02-001834 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 5 CONFORMED PERIOD OF REPORT: 20020812 ITEM INFORMATION: FILED AS OF DATE: 20020813 FILER: COMPANY DATA: COMPANY CONFORMED NAME: QUEST DIAGNOSTICS INC CENTRAL INDEX KEY: 0001022079 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 161387862 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-12215 FILM NUMBER: 02727804 BUSINESS ADDRESS: STREET 1: ONE MALCOLM AVE CITY: TETERBORO STATE: NJ ZIP: 07608 BUSINESS PHONE: 2013935000 MAIL ADDRESS: STREET 1: ONE MALCOLM AVE CITY: TETERBORO STATE: NJ ZIP: 07601 FORMER COMPANY: FORMER CONFORMED NAME: CORNING CLINICAL LABORATORIES INC DATE OF NAME CHANGE: 19960903 8-K 1 a33176.txt QUEST DIAGNOSTICS, INC. SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 ----------------------------- Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 ----------------------------- Date of Report (Date of earliest event reported): August 12, 2002 Quest Diagnostics Incorporated (Exact name of Registrant as specified in its charter) Delaware 1-12215 16-1387862 (State or other jurisdiction Commission File Number (I.R.S. Employer Identification of incorporation) Number)
----------------------------- One Malcolm Avenue Teterboro, New Jersey 07608 (201) 393-5000 (Address of principal executive offices and telephone number, including area code) ----------------------------- Item 9. Regulation FD Disclosure. ------------------------ On August 12, 2002, Kenneth W. Freeman, the Chief Executive Officer of Quest Diagnostics Incorporated, and Robert A. Hagemann, the Chief Financial Officer of Quest Diagnostics Incorporated, submitted to the Securities and Exchange Commission sworn statements pursuant to Securities and Exchange Commission Order 4-460 and Section 906 of the Sarbanes-Oxley Act of 2002. Signature Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: August 12, 2002 QUEST DIAGNOSTICS INCORPORATED By: /s/ Leo C. Farrenkopf, Jr. ----------------------------------------- Name: Leo C. Farrenkopf, Jr. Title: Vice President and Secretary Exhibit Index Exhibit 99.1: Statement under Oath of Chief Executive Officer dated August 12, 2002 Exhibit 99.2: Statement under Oath of Chief Financial Officer dated August 12, 2002 Exhibit 99.3 Statement Pursuant to 18. U.S.C.'SS'1350 of Chief Executive Officer dated August 12, 2002 Exhibit 99.4 Statement Pursuant to 18. U.S.C.'SS'1350 of Chief Financial Officer dated August 12, 2002 STATEMENT OF DIFFERENCES ------------------------ The section symbol shall be expressed as....................................'SS' EX-99 3 ex99-1.txt EXHIBIT 99.1 Exhibit 99.1 STATEMENT UNDER OATH OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFICER REGARDING FACTS AND CIRCUMSTANCES RELATING TO EXCHANGE ACT FILINGS I, Kenneth W. Freeman, state and attest that: (1) To the best of my knowledge, based upon a review of the covered reports of Quest Diagnostics Incorporated, and, except as corrected or supplemented in a subsequent covered report: o no covered report contained an untrue statement of a material fact as of the end of the period covered by such report (or in the case of a report on Form 8-K or definitive proxy materials, as of the date on which it was filed); and o no covered report omitted to state a material fact necessary to make the statements in the covered report, in light of the circumstances under which they were made, not misleading as of the end of the period covered by such report (or in the case of a report on Form 8-K or definitive proxy materials, as of the date on which it was filed). (2) I have reviewed the contents of this statement with the Audit and Finance Committee of Quest Diagnostics Incorporated. (3) In this statement under oath, each of the following, if filed on or before the date of this statement, is a "covered report": o the Annual Report on Form 10-K for the year ended December 31, 2001 of Quest Diagnostics Incorporated; o all reports on Form 10-Q, all reports on Form 8-K and all definitive proxy materials of Quest Diagnostics Incorporated filed with the Commission subsequent to the filing of the Form 10-K identified above; and o any amendments to any of the foregoing. /s/ Kenneth W. Freeman - ----------------------------- Kenneth W. Freeman Subscribed and sworn to Chairman of the Board and Before me this 12th day of Chief Executive Officer August 2002. August 12, 2002 /s/ Brenda Pereira ----------------------------------- Notary Public My Commission Expires: July 6, 2003 EX-99 4 ex99-2.txt EXHIBIT 99.2 Exhibit 99.2 STATEMENT UNDER OATH OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFICER REGARDING FACTS AND CIRCUMSTANCES RELATING TO EXCHANGE ACT FILINGS I, Robert A. Hagemann, state and attest that: (1) To the best of my knowledge, based upon a review of the covered reports of Quest Diagnostics Incorporated, and, except as corrected or supplemented in a subsequent covered report: o no covered report contained an untrue statement of a material fact as of the end of the period covered by such report (or in the case of a report on Form 8-K or definitive proxy materials, as of the date on which it was filed); and o no covered report omitted to state a material fact necessary to make the statements in the covered report, in light of the circumstances under which they were made, not misleading as of the end of the period covered by such report (or in the case of a report on Form 8-K or definitive proxy materials, as of the date on which it was filed). (2) I have reviewed the contents of this statement with the Audit and Finance Committee of Quest Diagnostics Incorporated. (3) In this statement under oath, each of the following, if filed on or before the date of this statement, is a "covered report": o the Annual Report on Form 10-K for the year ended December 31, 2001 of Quest Diagnostics Incorporated; o all reports on Form 10-Q, all reports on Form 8-K and all definitive proxy materials of Quest Diagnostics Incorporated filed with the Commission subsequent to the filing of the Form 10-K identified above; and o any amendments to any of the foregoing. /s/ Robert A. Hagemann - ---------------------- Robert A. Hagemann Subscribed and sworn to Chief Financial Officer Before me this 12th day of August 12, 2002 August 2002. /s/ Brenda Pereira ---------------------------------- Notary Public My Commission Expires: July 6, 2003 EX-99 5 ex99-3.txt EXHIBIT 99.3 Exhibit 99.3 STATEMENT PURSUANT TO 18 U.S.C.'SS' 1350 Pursuant to 18 U.S.C. 'SS' 1350, the undersigned certifies that, to the best of my knowledge, the Quarterly Report on Form 10-Q for the period ended June 30, 2002 of Quest Diagnostics Incorporated, as being filed with the Securities and Exchange Commission concurrently herewith, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 'SS' 78m or 78o(d)) and that the information contained in the Quarterly Report fairly presents, in all material respects, the financial condition and results of operations of Quest Diagnostics Incorporated. Dated: August 12, 2002 /s/ Kenneth W. Freeman ------------------------------------ Kenneth W. Freeman Chief Executive Officer EX-99 6 ex99-4.txt EXHIBIT 99.4 Exhibit 99.4 STATEMENT PURSUANT TO 18 U.S.C.'SS' 1350 Pursuant to 18 U.S.C. 'SS' 1350, the undersigned certifies that, to the best of my knowledge, the Quarterly Report on Form 10-Q for the period ended June 30, 2002 of Quest Diagnostics Incorporated, as being filed with the Securities and Exchange Commission concurrently herewith, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 'SS' 78m or 78o(d)) and that the information contained in the Quarterly Report fairly presents, in all material respects, the financial condition and results of operations of Quest Diagnostics Incorporated. Date: August 12, 2002 /s/ Robert A. Hagemann ----------------------------------- Robert A. Hagemann Chief Financial Officer -----END PRIVACY-ENHANCED MESSAGE-----